Filing Details
- Accession Number:
- 0000899243-22-027252
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-01 20:30:26
- Reporting Period:
- 2022-07-29
- Accepted Time:
- 2022-08-01 20:30:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1756262 | Transmedics Group Inc. | TMDX | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1430462 | I Tamer Khayal | C/O Transmedics Group, Inc. 200 Minuteman Road Andover MA 01810 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-07-29 | 5,681 | $0.28 | 51,757 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2022-07-29 | 7,823 | $2.21 | 59,580 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-07-29 | 13,504 | $40.01 | 46,076 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-07-29 | 5,681 | $0.00 | 5,681 | $0.28 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2022-07-29 | 7,823 | $0.00 | 7,823 | $2.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2023-05-29 | No | 4 | M | Direct | |
| 41,051 | 2027-06-22 | No | 4 | M | Direct |
Footnotes
- The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.
- The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $40.00 to $40.10, inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The option is fully vested.
Billionaire Hedge Funds
